VuCOMP is a renowned brand in the global medical technology industry, known for its innovative cancer detection and therapy solutions. With a passionate commitment to optimizing operational efficiency, clinician confidence, and patient outcomes, VuCOMP provides precise and powerful healthcare solutions. Their expertise lies in engineering advanced technologies that revolutionize cancer detection and therapy.

One of their flagship products is ProFound AI, a state-of-the-art software that significantly enhances the accuracy of digital breast tomosynthesis, making it the clear leader in breast AI. Additionally, ProFound AI Risk is designed to revolutionize personalized screening for 2D and 3D mammography. Both these products are licensed by Health Canada and have a CE Mark, ensuring their high quality and safety standards.

VuCOMP also offers advanced treatment options such as brain tumor treatment with Xoft IORT (Intraoperative Radiation Therapy). Their commitment to excellence and continuous innovation has made them a leading force in the medical technology field. With VuCOMP, healthcare professionals can rely on precise and powerful solutions to improve cancer detection and therapy outcomes for their patients